Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Leukemia; Leukemia, Lymphoid; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | ClinicalTrials |
| Brain Neoplasms; Glioblastoma; Glioma | Phase 2 | ClinicalTrials |
| Histiocytosis; Histiocytosis, Langerhans-Cell | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Lymphoid; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Lymphoid; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 4 | ClinicalTrials |
| Hodgkin Disease | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS